Accordingly, a previous study on sickle cell anemia demonstrated that the use of sodium nitroprusside could indirectly inhibit the TLR4 activation and reduce inflammatory responses and ROS (reacive oxygen species) levels (Nader et al., 2020). Here, TLR4 is linked to sickle cell disease.